ABSTRACT
INTRODUCTION

36
Opportunistic fungal infections have emerged as an important cause of morbidity and 37 mortality in immunodeficient patients (34). Amphotericin B (AMB) is considered one of 38 the most effective antifungal agents: it exhibits wide-spectrum activity against both 39 filamentous and yeast-like fungi, its pharmacokinetic and pharmacodynamic profiles are 40 superior to those of other antifungal agents and it is fungicidal, in contrast to most azoles 41 which are fungistatic (3, 39, 53) . The fungicidal effect is important since most patients (18, 37, (47) (48) (49) .
48
We conjugated AMB to arabinogalactan (AG) (18), which significantly increased 49 AMB's water solubility, reduced its toxicity, and resulted in an efficacy similar to that of 50 Fungizone TM (a deoxycholate micellar formulation) and AmBisome TM (a lipid-based 4 in leakage of monovalent ions and metabolites, which leads to cell death (5, 22, 45) . The 58 therapeutic use of AMB as an antifungal agent is based on its higher affinity to 59 ergosterol, the main sterol in fungal membranes, than cholesterol. In addition, AMB
60
generates a larger and more stable pore in ergosterol-containing membranes than in their 61 cholesterol-containing counterparts in mammalian cells (4, 12) . AMB channel assembly 62 in cholesterol-containing membranes requires the formation of AMB dimers or oligomers 63 in the surrounding media, whereas AMB monomers are sufficient for channel assembly 64 in ergosterol-containing membranes (6, 7, 25, 26, 31, 32) , suggesting that AMB 65 monomers are responsible for the antifungal selectivity. localized on the PM and in the vacuole (Fig. 1C,ii) . Shifting back to 5% glucose resulted in 10 GFP into numerous small intracellular structures and not into a single vacuole (Fig. 1C,iv) .
195
Treatment with a low concentration of AMB-AGC (1 µg/ml) resulted in an localization pattern similar to that of the "no drug" control (Fig. 1C,v) , whereas treatment 197 with 5 µg/ml AMB-AGC (Fig. 1C,vi) endosomal pH with that of the cytosol, due to internalization of the AMB polar channels.
207
We examined vacuolar pH with BCECF-AM (Fig. 2) , a fluorescent pH indicator that 208 accumulates in the yeast vacuole (1, 13, 24, 40, 59) . Treatment of C. albicans with AMB 209 resulted in a sharp pH increase from 6.20 to 6.64-6.75 (depending on AMB concentration),
210
followed by a decrease to pH 6.0-6.3. These changes in pH were even seen at the low 211 AMB concentration of 0.155 µg/ml (Fig. 2B ). The effect of treatment with AMB-AGC was 212 similar to that of AMB, but with slower kinetics (Fig. 2C) . endosomes, whereas conjugation of AMB (even at 400 µg/ml) to AG prevented this 232 redistribution (Fig. 4A) . Similar results were obtained for the human chemokine receptor 233 CXCR4 fused to GFP (Fig. S1 ). We also investigated the effects of AMB and AMB-AGC even after 2 h of treatment with 10 to 20 µg/ml free AMB (Fig. S2C) to REs, but partially inhibited this step, and changed the morphology of the EEs and REs.
312
These findings indicate that hTfnR trafficking is moderately affected by AMB treatment.
313
In addition, we found that AMB treatment increases pH in the REs, causing its 314 equalization with cytosolic pH. perturbations are an additional separate mechanism of AMB activity cannot be ruled out.
339
Further research is required to distinguish between these two possibilities. This might 
344
We previously showed in a mouse model that conjugation of AMB to AG causes 345 a dramatic reduction in AMB's toxicity, but does not change its therapeutic efficacy (18).
346
Similar data were obtained in the current in-vitro study. To explain the different effects of 347 AMB-AGC in mammalian and fungal cells, we examined its effect on membrane 348 perforation, post-endocytic trafficking, and intra-endosomal/vacuolar pH in these cells. 
